ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• eConsent: The Missing Ingredient To More Engaging Clinical Trials

  Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.

• Everest Group Life Sciences EDC Products PEAK Matrix^® Assessment 2024

  This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.

• 5 Key Takeaways From The FDA's Real-World Evidence Guidance

  With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

• Complex Randomization Delivered Successfully

  Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.

• Accelerating CRO Study Deployment At Scale

  A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.

• Why Research Sites Don't Use EMR As The Source Data Collection Tool

  Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

• Comprehensive Data Management For Non-Interventional Research

  Learn how your teams can embrace end-to-end clinical trial data platforms for non-interventional studies to improve user experience, boost patient engagement, ensure data quality, and achieve study success.

• What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution

  Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?

• The Advantages Of DCTs In Diabetes Research

  By harnessing technology platforms, discover how researchers can be better equipped to design studies for novel diabetes treatments that are safer, more efficient, and more effective.

• Transforming Field Rep Success

  As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.